Pancreatic Cancer Research

ResearcherChinese PLA General HospitalActive in the last 2 years

Ye Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0455-4556; OpenAlex author ID A5065556181. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Recognizing significance of propensity score matching and clinical practice in evaluating oncological survivals of pancreatic cancer. Co-author DOI 10.21037/hbsn-24-615↗
  2. Molecular Screening for Nigericin Treatment in Pancreatic Cancer by High-Throughput RNA Sequencing. Last author DOI 10.3389/fonc.2020.01282↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiming Zhao · 1 shared paper, 2025 · strength 0.33
  2. Wenbo Zou · 1 shared paper, 2025 · strength 0.33
  3. Rong Liu · 1 shared paper, 2025 · strength 0.33
  4. Chen Dai · 1 shared paper, 2020 · strength 0.11
  5. Zhihua Xu · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.